Cas 612087-86-2,N-Benzyl-N-(2-benzyl-indan-1-yl)-2-(1,3-dioxo-1,3-dihydro-isoindol-2-yl)-acetamide

612087-86-2

Post Buying Request

Basic information

Product Name: N-Benzyl-N-(2-benzyl-indan-1-yl)-2-(1,3-dioxo-1,3-dihydro-isoindol-2-yl)-acetamide
Synonyms:
CAS NO:612087-86-2
Molecular Formula:
Molecular Weight: 500.597
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: N-Benzyl-N-(2-benzyl-indan-1-yl)-2-(1,3-dioxo-1,3-dihydro-isoindol-2-yl)-acetamide(CAS DataBase Reference)
NIST Chemistry Reference: N-Benzyl-N-(2-benzyl-indan-1-yl)-2-(1,3-dioxo-1,3-dihydro-isoindol-2-yl)-acetamide(612087-86-2)
EPA Substance Registry System: N-Benzyl-N-(2-benzyl-indan-1-yl)-2-(1,3-dioxo-1,3-dihydro-isoindol-2-yl)-acetamide(612087-86-2)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 612087-86-2(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

612087-86-2 Suppliers

Recommended suppliers

612087-86-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 612087-86-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,1,2,0,8 and 7 respectively; the second part has 2 digits, 8 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 612087-86:
(8*6)+(7*1)+(6*2)+(5*0)+(4*8)+(3*7)+(2*8)+(1*6)=142
142 % 10 = 2
So 612087-86-2 is a valid CAS Registry Number.

612087-86-2Upstream product

612087-68-0 benzyl-(2-benzyl-indan-1-yl)-amine

612087-86-2Downstream Products

612087-86-2Relevant academic research and scientific papers

Urea derivatives useful as anticancer agents

-

, (2008/06/13)

The present invention relates to compounds of formula I And to pharmaceutically acceptable salts, hydrates and prodrugs thereof, wherein R1, R2, R3, R4, R5, R10, R11, b, m, n, p and v are as defined herein. The invention also relates to pharmaceutical compositions containing the above compounds and methods of treating hyperproliferative disorders in mammals by administering the above compounds.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 612087-86-2